» Authors » M Westerhausen

M Westerhausen

Explore the profile of M Westerhausen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 65
Citations 91
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Westerhausen M, Metzger M, Blendinger F, Levermann A, Fleischer M, Hofmann B, et al.
Annu Int Conf IEEE Eng Med Biol Soc . 2020 Jan; 2019:3927-3930. PMID: 31946731
The next generation of flexible, electrically active implants, such as brain implants or retina chips require a flexible, biostable as well as biocompatible passivation, ensuring a degradation-free usage for long...
2.
Hofmann W, Heil G, Zander C, Wiebe S, Ottmann O, Bergmann L, et al.
Ann Hematol . 2004 May; 83(8):498-503. PMID: 15156346
In an attempt to improve the complete remission (CR) rates and to prolong the remission duration especially in elderly patients > 50 years of age, we have used a combination...
3.
Westerhausen M
Angew Chem Int Ed Engl . 2002 Aug; 40(16):2975-7. PMID: 12203621
Even a century after the discovery of the Grignard reagents, similar compounds of the heavy alkaline earth metals are still lacking. Owing to the industrial need for such compounds (in...
4.
Westerhausen M, Krofta M, Mayer P, Warchhold M, Noth H
Inorg Chem . 2001 Feb; 39(21):4721-4. PMID: 11196945
The magnesiation of tri(tert-butyl)silylphosphane in THF yields tetrameric (tetrahydrofuran-O)magnesium tri(tert-butyl)silylphosphandiide 1. The central moiety is a slightly distorted Mg4P4 cube with tetracoordinate magnesium and phosphorus atoms. The reaction of dibutylmagnesium...
5.
Dierlamm J, Michaux L, Stefanova M, Eggert J, Leberecht P, Seeger D, et al.
Cancer Genet Cytogenet . 1999 Nov; 114(2):150-3. PMID: 10549273
A novel Philadelphia (Ph) variant translocation, t(Y;9;22)(q12;q34;q11), was detected in a 63-year-old man with a newly diagnosed chronic myeloid leukemia (CML). Reverse transcription polymerase chain reaction (RT-PCR) analysis revealed a...
6.
Kohne C, Schoffski P, Wilke H, Kaufer C, Andreesen R, Ohl U, et al.
J Clin Oncol . 1998 Feb; 16(2):418-26. PMID: 9469324
Purpose: To determine whether high-dose infusional fluorouracil (FU) is effectively modulated by leucovorin (LV), interferon (IFN) alpha-2b, or both when given to patients with metastatic colorectal cancer. Patients And Methods:...
7.
Westerhausen M, Hartmann M, Schwarz W
Inorg Chem . 1996 Apr; 35(9):2421-2426. PMID: 11666451
(1,2-Dimethoxyethane-O,O')lithium phosphanide (dme)LiPH(2) reacts with 1,2-bis(chloro-dimethylsilyl)ethane to give 2,2,5,5-tetramethyl-2,5-disilaphospholane, 1, as well as 1,1,4,4-tetramethyl-1,4-bis(2,2,5,5-tetramethyl-2,5-disilaphospholanyl)-1,4-disilabutane, 2 (P(2)Si(6)C(18)H(48), space group P&onemacr;, a = 943.3(2) pm, b = 1278.3(3) pm, c = 1413.3(2)...
8.
Fett W, Westerhausen M
Med Klin (Munich) . 1995 Nov; 90(11):661-4, 672. PMID: 8569636
No abstract available.
9.
Koch B, Eberhardt B, Westerhausen M
Biotech Histochem . 1995 Sep; 70(5):267-70. PMID: 8580212
Azure B-eosin APAAP staining allows simultaneous analysis of peripheral blood and bone marrow cells for hematological characteristics and immunological cell marker profiles. A defined sequence of staining procedures maintains characteristic...
10.
Gabius H, Gabius S, Joshi S, Koch B, Schroeder M, Manzke W, et al.
Planta Med . 1994 Feb; 60(1):2-7. PMID: 8134410
There is an obvious discrepancy between the popularity of mistletoe extracts and their classification as a non-conventional treatment modality with unproven efficacy in oncology. The commercial preparations suffer from several...